Here are four things to know.
1. Kaléo already covers out-of-pocket costs for commercially insured patients with a prescription for the naloxone auto-injector.
2. The company will now offer Evzio at no cost to commercially insured patients without a prescription via a pilot program in six states: Arizona, California, Colorado, Missouri, Nevada and Ohio. Kaléo will eventually expand the program to additional states.
3. The company will also allow all federal and state government agencies to directly purchase Evzio at a discounted price of $360 for a two-pack of auto-injectors.
4. The initiatives come a year after Kaléo faced congressional scrutiny over Evzio’s high price, which jumped from $690 in 2014 to $4,500 in 2017. The list price is now $4,100 for a two-pack, according to Reuters.
More articles on supply chain:
Study: 40% of providers have canceled surgeries over supply shortages
10 immensely overinflated hospital costs
Beating Amazon to the punch: Zipline launches drone to deliver medical supplies at 79 mph
.
